Zoetis discovers, develops and manufactures a diverse portfolio of animal health medicines and vaccines. It is complemented by diagnostic products, genetic tests, biodevices and a range of services which are designed to meet the needs of veterinarians, livestock farmers and pet owners. Zoetis is over 60 years in the animal health business and products are sold in well over 100 countries. In total it employs almost 10,000 people worldwide with annual revenue of $4.9 billion. About 60% of revenue comes from animal products and 40% from pets. Over 1,000 Zoetis employees are involved in R&D with 2,800 involved in helping and advising animal owners. They have over 25 manufacturing sites and recently acquired two more in Ireland. They have five big product lines with over 300 product categories. The key ranges are vaccines, parasticides, anti-infectives, medicinal feed additives and other pharma products. All animals including beef, dairy, swine, poultry, sheep, fish, dogs, cats and horses are catered for with products. Relationships with Irish dairy farmers are supported by the technical and veterinary specialists who provide in-depth technical expertise and disease education. By having an on-the-ground presence, Zoetis can react quickly to local-market needs and be well positioned to help our customers continually increase their business productivity and sustain long-term success.

BioNua is now part of Zoetis Ireland based in Tullamore and operating a 20,000 square foot facility which will focus on process development and manufacture of biopharmaceutical drug substance for clinical trials and commercial product. Recently Zoetis were confirmed as the buyers of the 84 acre site in Rathdrum, Co Wicklow. Zoetis said they will gradually phase in operations at the site from later this year. They say the Rathdrum facility will play a vital role in the company’s global manufacturing and supply network.